Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen-activated protein kinase signalling pathway
- Reference:
- Oncology Reports
- 2015
- 33
- 840-848
- DOI:
- 10.3892/or.2014.3626
Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds